Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study of Apitegromab Treatment in Children Under 2 Years Old with Spinal Muscular Atrophy (SMA)

    Recruiting

    2 1 1
    Investigated Drugs:
    Belgium France Italy The Netherlands Spain
  • Study on the Early Use of Risdiplam for Children with Spinal Muscular Atrophy After Gene Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Poland
  • Study on the Effectiveness and Safety of Risdiplam for Children with Spinal Muscular Atrophy After Gene Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Poland
  • Study of BIIB115 in patients aged 15‑60 years with spinal muscular atrophy who are treatment‑naïve or previously treated with risdiplam

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study on the Safety and Tolerability of BIIB115 for Children with Spinal Muscular Atrophy Previously Treated with Gene Therapy

    Not recruiting

    1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Germany Italy The Netherlands Poland
  • Long-term Safety Study of Onasemnogene Abeparvovec for Patients with Spinal Muscular Atrophy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Denmark France Italy The Netherlands Spain
  • Study on the Safety and Efficacy of RO7204239 and Risdiplam for Patients with Spinal Muscular Atrophy

    Not recruiting

    4 1 1
    Investigated Diseases:
    Belgium Croatia France Germany Italy The Netherlands +3
  • Study of Clenbuterol vs Placebo in Adult Patients with Spinal and Bulbar Muscular Atrophy (SBMA)

    Not recruiting

    2 1 1
    Investigated Drugs:
    Italy
  • Study of NMD670 tablets to improve muscle strength in adults with Type 3 spinal muscular atrophy who can walk

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Denmark Germany Italy The Netherlands Spain
  • Study on the Safety and Pharmacokinetics of Risdiplam in Infants with Spinal Muscular Atrophy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Germany Italy The Netherlands Norway Poland